The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group.

Area of Science:

• Genetics
• Immunology
• Neurology

Background:

• The clinical benefits of interferon (IFN) beta therapy for multiple sclerosis (MS) are not fully understood.
• Polymorphisms within the IFNB gene were investigated as a potential explanation for varying treatment responses in MS patients.

Purpose of the Study:

• To investigate the role of IFNB gene polymorphisms in multiple sclerosis (MS) susceptibility.
• To identify potential genetic risk factors for MS by examining IFNA genes and their association with the disease.

Main Methods:

• Single-strand conformation polymorphism (SSCP) analysis and sequencing were used to screen the IFNB gene.
• Linkage disequilibrium (LD) analysis was performed between IFNB and IFNA microsatellite alleles.
• Functional polymorphisms in IFNA10 and IFNA17 genes, including premature stop codons and amino acid substitutions, were analyzed.

Main Results:

• No significant association was found between IFNB gene alleles and MS risk.
• A significant linkage disequilibrium was observed between an IFNB allele and an IFNA microsatellite allele in MS patients, indicating a disease-related haplotype.
• Specific IFNA gene polymorphisms, such as non-functional IFNA17 alleles, were associated with a significantly increased risk of developing MS.
• LD analysis suggested IFNA14, IFNA16, or IFNA5 as additional candidate genes for MS predisposition.

Conclusions:

• The IFNB gene is excluded as a direct cause of MS predisposition.
• The study provides the first evidence implicating specific IFNA genes as predisposing factors for multiple sclerosis.
• These findings highlight the importance of IFNA gene variations in the genetic landscape of MS.